A9662 | Relates to capping cost sharing for antiviral COVID-19 therapeutics | Smith & MosesOfficial Title
Relates to capping cost sharing for antiviral COVID-19 therapeutics
2023-2024 SessionDavid WeprinAffects: Insurance Law Status
In Assembly Committee
Insurance
Impact Rating
Unable to calculate
Passage Likelihood
Unable to calculate